HanAll Biopharma Co., Ltd. total revenue, net income and dynamics of changes in South Korean won today
HanAll Biopharma Co., Ltd. revenue for the past few reporting periods. The dynamics of HanAll Biopharma Co., Ltd. net income fell by -1 751 379 030 ₩. The assessment of the dynamics of HanAll Biopharma Co., Ltd. net income was made in comparison with the previous report. These are the main financial indicators of HanAll Biopharma Co., Ltd.. The financial report schedule from 31/03/2019 to 31/03/2021 is available online. HanAll Biopharma Co., Ltd. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of the "total revenue of HanAll Biopharma Co., Ltd." on the chart is marked in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Dates of HanAll Biopharma Co., Ltd. finance reports: 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of HanAll Biopharma Co., Ltd. is 31/03/2021. Gross profit HanAll Biopharma Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit HanAll Biopharma Co., Ltd. is 17 770 309 110 ₩
HanAll Biopharma Co., Ltd. quarterly report dates
Cost of revenue HanAll Biopharma Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue HanAll Biopharma Co., Ltd. is 10 028 423 890 ₩ Total revenue HanAll Biopharma Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue HanAll Biopharma Co., Ltd. is 27 798 733 000 ₩ Operating income HanAll Biopharma Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income HanAll Biopharma Co., Ltd. is 5 395 661 090 ₩
Net income HanAll Biopharma Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income HanAll Biopharma Co., Ltd. is 4 525 555 100 ₩ Current assets HanAll Biopharma Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets HanAll Biopharma Co., Ltd. is 131 328 054 240 ₩ Total assets HanAll Biopharma Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets HanAll Biopharma Co., Ltd. is 203 637 791 260 ₩
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
17 770 309 110 ₩
12 268 498 110 ₩
12 128 975 710 ₩
12 757 670 950 ₩
13 174 331 230 ₩
16 584 544 270 ₩
18 847 782 730 ₩
14 074 274 190 ₩
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
10 028 423 890 ₩
9 521 747 780 ₩
9 985 363 330 ₩
9 843 371 310 ₩
12 966 610 140 ₩
11 410 839 520 ₩
10 968 204 750 ₩
10 425 455 570 ₩
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
27 798 733 000 ₩
21 790 245 890 ₩
22 114 339 040 ₩
22 601 042 260 ₩
26 140 941 370 ₩
27 995 383 790 ₩
29 815 987 480 ₩
24 499 729 760 ₩
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
26 140 941 370 ₩
27 995 383 790 ₩
29 815 987 480 ₩
24 499 729 760 ₩
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
5 395 661 090 ₩
445 125 760 ₩
1 031 517 290 ₩
1 616 243 420 ₩
3 001 255 560 ₩
4 530 969 230 ₩
7 005 881 490 ₩
2 551 499 140 ₩
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
4 525 555 100 ₩
6 276 934 130 ₩
3 713 940 480 ₩
5 896 731 720 ₩
6 226 529 540 ₩
5 457 020 220 ₩
4 192 214 970 ₩
3 298 586 040 ₩
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
2 513 976 000 ₩
2 589 025 000 ₩
2 134 820 000 ₩
2 551 415 000 ₩
1 290 660 000 ₩
2 886 382 000 ₩
3 060 930 000 ₩
2 812 638 000 ₩
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
22 403 071 910 ₩
21 345 120 130 ₩
21 082 821 750 ₩
20 984 798 840 ₩
23 139 685 810 ₩
23 464 414 560 ₩
22 810 105 990 ₩
21 948 230 620 ₩
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
131 328 054 240 ₩
129 364 551 690 ₩
129 471 133 510 ₩
129 040 241 280 ₩
134 295 046 210 ₩
138 447 374 610 ₩
138 985 214 670 ₩
123 633 512 000 ₩
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
203 637 791 260 ₩
220 132 430 900 ₩
207 307 553 850 ₩
197 551 393 920 ₩
191 383 402 870 ₩
184 150 630 130 ₩
181 340 206 080 ₩
163 866 001 000 ₩
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
10 543 393 970 ₩
4 200 417 300 ₩
6 983 408 470 ₩
9 442 422 060 ₩
6 120 056 030 ₩
21 375 562 550 ₩
10 935 076 990 ₩
19 028 848 000 ₩
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
27 384 696 660 ₩
25 927 414 820 ₩
28 094 188 520 ₩
18 834 900 000 ₩
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
50 965 912 360 ₩
53 875 121 200 ₩
56 563 297 080 ₩
43 451 291 000 ₩
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
26.63 %
29.26 %
31.19 %
26.52 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
163 493 425 280 ₩
181 273 482 970 ₩
168 122 279 250 ₩
156 774 405 310 ₩
140 417 490 510 ₩
130 275 508 930 ₩
124 776 909 000 ₩
120 414 710 000 ₩
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-4 363 198 280 ₩
19 055 228 800 ₩
4 287 316 090 ₩
1 511 572 000 ₩
Last revenue report of HanAll Biopharma Co., Ltd. was 31/03/2021. According to last financial report total revenue in HanAll Biopharma Co., Ltd. was 27 798 733 000 South Korean won and changed by +13.47% since last year. Net income in HanAll Biopharma Co., Ltd. was 4 525 555 100 ₩ in last quartal, net income changes to +37.2%.
Current cash HanAll Biopharma Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash HanAll Biopharma Co., Ltd. is 10 543 393 970 ₩
